Progression of BRAF V600E+ Metastatic NSCLC

preview_player
Показать описание
Joshua Bauml, MD, shares his opinion on repeat biopsy and molecular testing after progression of BRAF V600E–mutated metastatic non–small cell lung cancer.

  1. Targeted Oncology
  2. targeted oncology
  3. oncology
  4. cancer
Рекомендации по теме
Progression of BRAF 0:04:58

Progression of BRAF V600E+ Metastatic NSCLC

Targeting BRAF V600E 0:05:19

Targeting BRAF V600E in metastatic colorectal cancer: where are we today?

Treatment approaches for 0:01:17

Treatment approaches for BRAF V600E mutant metastatic colorectal cancer

The evolving treatment 0:02:28

The evolving treatment paradigm for BRAF V600E-mutant mCRC

Targeted Therapies for 0:03:53

Targeted Therapies for BRAF V600E-Mutated mNSCLC

Understand the critical 0:00:55

Understand the critical role of BRAFV600E Mutation test in cancer detection & personalized treat...

Progress Made in 0:01:42

Progress Made in Treating BRAF V600E+ Metastatic NSCLC

Impact of BRAF-V600E 0:10:08

Impact of BRAF-V600E mutation on the tumour microenvironment and associated genomic alterations ...

How to treat 0:00:42

How to treat BRAF Positive Patients with Metastatic Melanoma? | Onc Brothers #2023 #oncology #cancer...

Novel treatment strategies 0:01:26

Novel treatment strategies for BRAF V600E-mutant NSCLC

What is a 0:01:49

What is a BRAF-V600E mutation?

How BRAF V600E-Mutated 0:01:18

How BRAF V600E-Mutated CRC is Treated Differently Than Other Cancers

What is the 0:20:52

What is the optimal therapy for BRAF mutant metastatic colorectal cancer?

BRAF-Mutated mCRC: From 1:35:47

BRAF-Mutated mCRC: From Diagnosis to Treatment

Treating BRAF V600E-mutant 0:02:56

Treating BRAF V600E-mutant NSCLC with dabrafenib and trametinib

BRAF Targeted Therapy 0:22:44

BRAF Targeted Therapy - Melanoma Education Symposium, Peter Boasberg MD

Dr. Long on 0:01:52

Dr. Long on Dabrafenib/Trametinib in BRAF V600E-Mutant Melanoma

Case 1: BRAF-Mutated 0:04:54

Case 1: BRAF-Mutated Metastatic Colorectal Cancer

Debate: Are novel 0:15:52

Debate: Are novel targets such as HER2 ready for prime time in colorectal cancer? - No

Why is it 0:01:43

Why is it so important to know if you have BRAF-V600E?

BEACON: Encorafenib plus 0:05:04

BEACON: Encorafenib plus cetuximab with or without binimetinib for BRAF V600E–mutant metastatic ......

Targeting BRAF in 0:04:19

Targeting BRAF in Metastatic CRC

Real-World Management of 0:02:24

Real-World Management of Patients with BRAF-V600E mCRC

Prognosticating BRAF-Mutant mCRC 0:02:18

Prognosticating BRAF-Mutant mCRC